Video Experimental Relacionado
Updated: Aug 12, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Análisis de riesgos en la preparación de medicamentos citotóxicos mediante FMECA en una Unidad Centralizada de
Wiem Ben Ayed1, Azza Ben Haddada2, Azza Ben Said3
1, Docteure en pharmacie, Assistante hospitalo-universitaire en pharmacie, Institut Salah Azaiz, Tunis; Faculté de pharmacie, Université de Monastir, Monastir; Laboratoire de Développement Chimique, Galénique et Pharmacologique du Médicament (LR12ES09), Faculté de Pharmacie de Monastir, Université de Monastir, Monastir, Tunisie.
Background:
The preparation of injectable chemotherapy drugs is a critical process, given their toxicity and the large number of stakeholders involved. As such, systematic and proactive risk assessment is required.
Objective:
To analyze the risks associated with the cytotoxic drug preparation process using the failure mode, effects, and criticality analysis (FMECA) method within a centralized cytotoxic drug preparation unit (CCDPU).
Methods:
An analytical study was conducted in a CCDPU over a 6-month period. The risk analysis was performed using the FMECA method. An action plan was developed to address critical scenarios. A second FMECA cycle was conducted to evaluate the effectiveness of the implemented actions.
Results:
A total of 189 failure modes were identified, of which 2% were deemed unacceptable and 30% were tolerable when controlled. An action plan was developed based on training, double visual inspection, and the implementation of analytical control. During the follow-up FMECA, a reduction of 23% in the overall criticality index was observed, with a significant improvement in criticality levels. Of the 60 actions, 73% were completed, and an updated action plan was proposed.
Conclusion:
These results demonstrate the CCDPU team's genuine commitment to risk management and the usefulness of the FMECA method in a continuous improvement approach to the cytotoxic preparation circuit.
Más Videos Relacionados
Videos de Conceptos Relacionados
FDA Approved Drugs: Changes to Approved Drugs
Mutagenicity and Carcinogenicity

